Fluid Biomed
2 known investors
Fluid Biomed develops the ReSolv stent, a hybrid polymer-metal, self-expanding flow-diverting stent designed to treat brain aneurysms and reduce the risk of rupture and stroke. The device uses a dissolving polymer scaffold to promote blood vessel healing and simplify non-invasive follow-up imaging, and is currently limited to authorized clinical investigations.
BiotechHealthtechMedical Devices